BioSpace News Archive

Business

Solid Biosciences Provides Third Quarter 2022 Business Update and Financial Results

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today reported financial results for the third quarter ended September 30, 2022 and provided a business update.

November 10, 2022
·
14 min read
Biotech Bay

Medable Named Leader in Decentralized Clinical Trial Products Assessment for Second Consecutive Year by Everest Group

Medable Inc. today announced that it was named a Leader in the “Decentralized Clinical Trial Products PEAK Matrix® Assessment 2022” by Everest Group for the second consecutive year.

November 10, 2022
·
4 min read
Myriad Genetics Announces UroSuite™, an Industry-First Suite of Genetic Tests for Prostate Cancer, Giving Urologists Access to Timely, Data-driven Medical Information

Myriad Genetics, Inc. today announced the launch of UroSuite, a comprehensive suite of genetic risk assessment tests that cover every stage of prostate cancer care.

November 10, 2022
·
3 min read
Business

Senti Bio Reports Third Quarter Financial Results and Pipeline Updates

Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company innovating next-generation cell and gene therapies using its proprietary gene circuit platform, today reported financial results for the third quarter ended September 30, 2022.

November 10, 2022
·
14 min read
MIMEDX to Present at Upcoming Investor Conferences

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that senior management will present at the following investor conferences.

November 10, 2022
·
1 min read
Business

RAPT Therapeutics Reports Third Quarter 2022 Financial Results

RAPT Therapeutics, Inc. today reported financial results for the quarter and nine months ended September 30, 2022.

November 10, 2022
·
7 min read
Pharm Country

Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences

Intra-Cellular Therapies, Inc. today announced that it will participate at two upcoming investor conferences: J.P. Morgan Equity Opportunities Forum Monday, November 14 – Tuesday, November 15, 2022 in Miami, FL Evercore ISI 5th Annual HealthCONx Virtual Conference Tuesday, November 29, 2022.

November 10, 2022
·
1 min read
Biotech Beach

aTyr Pharma to Present at Upcoming Investor Conferences

aTyr Pharma, Inc. today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a corporate overview at three upcoming investor conferences scheduled to take place in November and December 2022.

November 10, 2022
·
1 min read
Pharm Country

LianBio to Participate in Upcoming Investor and Industry Events

LianBio, a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, announced that members of the management team will participate in the following upcoming investor and industry conferences.

November 10, 2022
·
1 min read
Business

Nanox Announces Third Quarter 2022 Financial Results and Provides Business Update

NANO-X IMAGING LTD announced results for the third quarter ended September 30, 2022 and provided a business update.

November 10, 2022
·
24 min read